Literature DB >> 8692150

[Adjuvant chemotherapy for advanced gastric cancer].

H Furukawa1, M Hiratsuka, T Iwanaga, S Imaoka, O Ishikawa, T Kabuto, Y Sasaki, M Kameyama, H Ohigashi, S Nakamori, H Nakano, T Yasuda.   

Abstract

For recent 40 years, many authors reported the results of adjuvant chemotherapy for advanced gastric cancer including 5-fluorouracil, uracil and tegafur, mitomycin C, cytosine arabinoside. OK-432 adriamycin, methotrexate, and cis-pltatin in solitary use of combinations. It is difficult to find a standard effective adjuvant chemotherapy for advanced gastric cancer in these reports. The reasons of this unclearness were as follows; (1) In phase III studies, surgery alone was not a control group in some reports. (2) The number of patients was too small to evaluate statistically. (3) Inter-institutional differences had important roles in the results of multicenter study in the other studies. For the future plans on adjuvant chemotherapy, it is important to make a simple designed protocol, and perform it as a multicenter study including institutions with minimum inter-institutional differences.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8692150

Source DB:  PubMed          Journal:  Nihon Geka Gakkai Zasshi        ISSN: 0301-4894


  2 in total

1.  Importance of positive peritoneal lavage cytology findings in the stage grouping of gastric cancer.

Authors:  T Suzuki; T Ochiai; H Hayashi; K Nakajima; A Yasumoto; E Hishikawa; H Shimada; F Horiuchi; S Ohki; K Isono
Journal:  Surg Today       Date:  1999       Impact factor: 2.549

2.  Circulating tumor cells expressing cancer stem cell marker CD44 as a diagnostic biomarker in patients with gastric cancer.

Authors:  Toru Watanabe; Tomoyuki Okumura; Katsuhisa Hirano; Tetsuji Yamaguchi; Shinichi Sekine; Takuya Nagata; Kazuhiro Tsukada
Journal:  Oncol Lett       Date:  2016-11-24       Impact factor: 2.967

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.